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in Children
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Charles E. McCulloch, PhD; Sharon A. Kidd, MPH, PhD; Michael D. Cabana, MD, MPH;
Mary-Margaret Chren, MD; Katrina Abuabara, MD, MA, MSCE
IMPORTANCE Pruritus, a hallmark of atopic dermatitis (AD), is thought to disrupt sleep, yet
little is known about how variations in disease activity and severity of this common childhood
conditionmay be associated with sleep patterns over time.
OBJECTIVE To determine whether children with active AD have impaired sleep duration and
quality at multiple time points throughout childhood and whether disease severity affects
sleep outcomes.
DESIGN, SETTING, AND PARTICIPANTS This longitudinal cohort study used data of children
enrolled in the Avon Longitudinal Study of Parents and Children, a population-based birth
cohort in Avon, United Kingdom. Participants were children (N = 13 988) alive at 1 year and
followed up with repeatedmeasures of self-reported AD and sleep through 16 years of age.
This study was based on data collected from 1990 to 2008. Data analysis was performed
from September 2017 to September 2018.
MAIN OUTCOMES ANDMEASURES Standardizedmeasure of sleep duration and composite
measure of sleep quality, including nighttime awakenings, early morning awakenings,
difficulty falling asleep, and nightmares, were repeated at multiple time points between
2 and 16 years of age.
RESULTS The study sample comprised 13 988 children (7220male [51.6%]) followed up for
a median (interquartile range [IQR]) duration of 11 (5-14) years. Of this total, 4938 children
(35.3%)met the definition of having atopic dermatitis between 2 and 16 years of age. Total
sleep duration was similar between children with active AD and without AD at all ages, and
the average estimated difference across childhood was a clinically negligible difference of
2 minutes less per day for children with AD (95% CI, −4 to 0minutes). In contrast, children
with active ADweremore likely to report worse sleep quality at all time points, with a nearly
50% higher odds of experiencing more sleep-quality disturbances (adjusted odds ratio [aOR],
1.48; 95% CI, 1.33 to 1.66). Children with more severe active disease (quite bad or very bad
AD: aOR, 1.68; 95% CI, 1.42 to 1.98) and with comorbid asthma or allergic rhinitis (aOR, 1.79;
95% CI, 1.54 to 2.09) had worse sleep quality. However, even children with mild AD (OR, 1.40;
95% CI, 1.27 to 1.54) or inactive AD (OR, 1.41; 95% CI, 1.28 to 1.55) had statistically significantly
increased odds of impaired sleep quality.
CONCLUSIONS AND RELEVANCE Atopic dermatitis appeared to be associated with impaired
sleep quality throughout childhood; thus, it is suggested that clinicians should consider sleep
quality among all children with AD, especially those with comorbid asthma or allergic rhinitis
and severe disease, and that interventions to improve sleep quality are needed.
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A topic dermatitis ranks among the largest componentsof the nonfatal disease burden worldwide.1 Sleepdisturbanceshavebeen identifiedas central toquality-
of-life decrements in atopic dermatitis,2,3 but little is known
about their association with sleep in the general population.
Pruritus, ahallmarkofatopicdermatitis, isoftenworst atnight,
resulting in scratching that may interfere with the process of
falling asleep and causedisruptions in ongoing sleep.4,5 Small
polysomnography and actigraphy studies among clinic-
based populations have found that children with atopic der-
matitis aremore restless in their sleep, awakenmoreoften, and
spendmore time awake after the onset of sleep.6-10 Adequate
sleep is critical towell-beingandhealth; in children, acute and
chronic sleep disturbances have been associated with a wide
rangeofcognitive,mood,andbehavioral impairmentsandhave
been linked to poor educational performance.11-13
Atopic dermatitis has a chronic relapsing and remitting
course, and it is unknown how variations in disease activity
and severity affect sleepatdifferentperiods throughout child-
hood. Longitudinal studies can help characterize and quan-
tify the burden of atopic dermatitis–associated sleep loss
during these critical developmental periods.We aimed to de-
termine whether children with active atopic dermatitis have
impairedsleepdurationandquality throughoutchildhoodand
whether the severity of atopic dermatitis affects sleep out-
comes in a population-based birth cohort.
Methods
We performed a longitudinal cohort study using data col-
lected from 1990 to 2008 from the Avon Longitudinal Study
ofParents andChildren (ALSPAC). Participants inALSPACpro-
videdwritten informed consent, andethical approvalwas ob-
tained from the ALSPAC Ethics and Law Committee and the
LocalResearchEthicsCommittees.Thepresent studywascon-
sidered exempt from review by the University of California,
SanFrancisco InstitutionalReviewBoardbecauseallof thedata
obtained by investigatorswere fully deidentified. Data analy-
sis was performed from September 2017 to September 2018.
Participants
Pregnant women residing in Avon, United Kingdom,were re-
cruited between 1990 and 1992 and followed up in the ensu-
ing 2 decades with standardized questionnaires and clinical
assessment visits, as described in detail elsewhere.14,15 The
ALSPACstudyenrolled a total of 14 541pregnancies,which re-
sulted in 14062 live births, ofwhich 13988were alive at 1 year
of age. The current study sample is limited to children alive
at 1 year of age and includes assessments through age 16
(n = 11 620; 83% of those alive at 1 year of age). The ALSPAC
website contains details of all of the data available through a
fully searchable data dictionary and variable search tool.16
Exposure
The primary exposure was atopic dermatitis annual period
prevalence,measured by a standardized question about flex-
ural (joints and creases) dermatitis answered by the mother
or the child (latest time point only) at 12 time points between
age 6 months and 16 years: Has your child had an itchy, dry
skin rash in the joints and creases of his body (eg, behind the
knees, elbows, under the arms) in the past year? This ques-
tion is comparable to thatused in the large International Study
of Asthma and Allergies in Childhood (ISAAC).17 Individuals
were considered to have active atopic dermatitis if they had
at least 2 reports of flexural dermatitis, up to and including the
time point being considered.18-20 On the first report of flex-
ural dermatitis, individuals were categorized as being inde-
terminate for atopic dermatitis and not included in the con-
trol group for that time point. Disease severity was assessed
at each timepoint by aquestion that askedmothers to catego-
rize their child’sdiseaseover thepastyear asnoproblem,mild,
quite bad, or very bad. Finally, children were classified as
having inactive atopic dermatitis if theymet the definition of
active atopic dermatitis previously but responded negatively
at the time point being considered.
Sleep Outcomes
Sleep duration was assessed by standardized questionnaires
at 8 time points (30, 42, 57, 69, 81, 115, 140, and 186 months)
betweenages2and 16years.Nighttimesleepdurationwascal-
culated on the basis of maternal or self-report (16 years only)
of the time the child usually went to sleep and usually woke
up in the morning. Mothers were also asked about daytime
sleepdurationat5 timepointsbetweenages2and7years.Total
sleep duration was calculated by adding nighttime and day-
time duration up until age 7 years, and it was equal to night-
timesleepdurationaloneafter age7years.Bothnighttimeand
total sleep duration were found to be approximately nor-
mally distributed.
Sleep quality was assessed using 4 standardized ques-
tions at 6 time points (30, 42, 57, 69, 81, and 115 months) be-
tween ages 2 and 10 years. Mothers were asked about night-
timeawakenings (≥1pernight) andwhether the child regularly
experienced early morning awakenings, difficulty falling
asleep,andnightmaresover thepastyear.Responseswereana-
lyzed individually and combined into a composite sleep-
Key Points
Question Do children with atopic dermatitis experience impaired
sleep duration and sleep quality throughout childhood, and do
disease severity and activity affect their sleep?
Findings In this longitudinal cohort study of 13 988 children,
atopic dermatitis was statistically significantly associated with
impaired sleep quality but not sleep duration throughout
childhood. Sleep impairment was more common among children
with more severe disease and with comorbid asthma or allergic
rhinitis, and the risk remained elevated even among children with
mild and inactive atopic dermatitis.
Meaning These findings suggest that clinicians should consider
sleep quality among all children with atopic dermatitis, especially
those with comorbid asthma or allergic rhinitis and severe disease;
it appears interventions to improve sleep quality are needed for
this population.
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quality outcome scored from0 to 4, assigning 1 point for each
item.
Additional Covariates
Potential confounders and effect modifiers were identified
from the literature and incorporated into a directed acyclic
graph that was used to guide the modeling strategy
(Figure 1).22-27 These covariates included child and mother
demographic characteristics (child sex, age, and race/
ethnicity aswell asmaternal age at delivery), indicators of so-
cioeconomic status, household smoking exposure, and co-
morbid asthma or allergic rhinitis. Socioeconomic status was
measured using prenatal questionnaires collected from par-
ents at study enrollment, including the highest educational
qualification of the mother; social class based on occupation
(highest of either parent); household crowding index (num-
ber of people living in the household divided by the number
of rooms in the house); and a financial difficulties score as-
sessing the mother’s self-reported difficulty to afford food,
clothing,heating, rentormortgage, and itemsnecessary tocare
for her baby.
Time-varying covariates included comorbid asthmaor al-
lergic rhinitis and household smoking exposure. A child was
determinedtohavecomorbidasthmaorallergic rhinitis ateach
timepoint examined if themother reported asthmaand/or al-
lergic rhinitis symptomsat that timepoint, basedonstandard-
ized questions similar to those used in the ISAAC study.17 Fi-
nally, models also included ameasure of household smoking
exposure,assessedbyamaternalquestionnaireabout thenum-
ber of smokers living in thehousehold atmultiple timepoints
throughout childhood.
Missing Data
As has been described in detail elsewhere, the ALSPAC co-
hort has both intermittent missing data and attrition (ie, loss
to follow-up).14 For example, themean response rate to 12 sur-
veys during the adolescence phasewas 48%, but 75% of indi-
viduals responded at least once during adolescence.Multiple
imputation was performed to impute missing exposure, out-
come, and covariate data. Iterative chained equations were
used, asmost variables in themodels did not follow a normal
distribution. Fifty imputeddata setswere generated andused
to repeat primary analyses.
Statistical Analysis
Cross-sectional regression analyses were performed to com-
pare sleepoutcomesbetweenchildrenwithandchildrenwith-
outatopicdermatitis at each timepoint (linearmodels for sleep
duration, logistic models for binary sleep-quality outcomes,
andordered logistic regressionmodels for thecomposite sleep-
quality measure). Longitudinal analyses with repeated mea-
sures of the exposure, outcome, and time-varying covariates
(asthma or allergic rhinitis and household smoking expo-
sure) were then conducted using mixed-effects models with
random slopes and intercepts for each individual. For all lon-
gitudinal analyses, table legends include the total number of
individuals included in each model and the mean number of
observations (ie, number of time points used) per individual.
Figure 1. Directed Acyclic Graph
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Parent atopy
Child race/ethnicity
Child sex Maternal age at delivery
Household smoking
Child asthma or allergic rhinitis
Atopic dermatitis
Child age
Sleep
A directed acyclic graph represents associations between covariates and
primary exposure and outcome. Gray circles represent ancestors of the
exposure and outcome (ie, confounders), blue circles represent ancestors of
the outcome (ie, causal determinants of the outcome), and light blue circles
represent unobserved (ie, latent) variables. Green lines represent causal paths,
and gray lines represent biasing paths. Theminimally sufficient adjustment set
represents covariates such that the adjustment for this set of variables will
minimize confounding bias when estimating the association between the
exposure and the outcome. Theminimally sufficient adjustment set was
determined using the DAGitty software.21 Child comorbid asthma or allergic
rhinitis was considered to be a collider, which was appropriately accounted for
by adjusting for additional variables contained on the backdoor paths shared by
this collider. The final minimally sufficient adjustment set comprised child sex,
age, race/ethnicity, and comorbid asthma or allergic rhinitis; maternal age at
delivery; socioeconomic status (SES); and household smoking exposure.
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Theminimally sufficient adjustment setwasdeterminedusing
a directed acyclic graph (Figure 1). We tested for interactions
betweenatopicdermatitis andcomorbidasthmaorallergic rhi-
nitis, child’s age, child sex, andmaternal educational level. Of
these variables, only the interactionwith comorbid asthmaor
allergic rhinitis was found to be statistically significant for
sleep-quality outcomes (P < .05); thus, these results are pre-
sented stratified by asthma or allergic rhinitis status. All sta-
tistical analyses were performed using Stata, version 14.2
(StataCorp Inc).
Results
Thestudysamplewascomposedof 13988children (7220male
[51.7%]) followed up for a median (interquartile range [IQR])
duration of 11 (5-14) years. Overall, 4938 children (35.3%)met
the definition of atopic dermatitis between 2 and 16 years of
age. Childrenwith atopic dermatitisweremore likely to be fe-
male, have comorbid asthma or allergic rhinitis, have a fam-
ily history of atopic conditions, be from a family of a high so-
cial class, and have a mother with a high level of education
(Table 1). The annual period prevalence of active atopic der-
matitis ranged from13%to21%fromage2 to 16years, and22%
to40%of individualswithatopicdermatitis reportedquitebad
to very bad disease at any given time point (eTable 1 in the
Supplement).
Sleep Duration
Themean (SD)nighttime sleepduration ranged from11.2 (1.0)
hours at 2 years of age to 8.7 (0.9) hours at 16 years of age. The
median (IQR) daytime sleep duration was 30 (0-90) minutes
at 2 years of age and 0 minutes thereafter. Overall, through-
out childhood, nighttime sleep durationwas similar between
childrenwithactiveatopicdermatitis and thosewithoutatopic
dermatitis (Table 2). In adjustedmodels, the estimateddiffer-
encewas 0minutes (95%CI, −2 to 2), andwe did not find any
statistically significant differences or gradient by atopic der-
matitis severity levels. For total sleepduration (includingday-
timenaps though age 7 years),we found a statistically signifi-
cantbut clinicallynegligibledifference: individualswithactive
atopic dermatitis were estimated to sleep a mean 2 minutes
less per day throughout childhood (95% CI, −4 to 0), and this
association was similar across all disease severity levels
(Table 2).
Sleep Quality
At any point between 2 and 10 years of age, themean number
of sleep disturbances ranged from 1.3 to 1.8, and 72% to 87%
of the population experienced 1 ormore sleep-quality distur-
bances.Overall, 5075 (50.0%)of 10 159children reported regu-
larlywaking at least once in thenight at age 2 years,whichde-
creased to 1001 (13.5%)of 7435childrenbyage 10years.A large
proportion of all children reported regularly waking early in
themorning (36.3% [2806of 7739] to 58.2% [5930of 10 195]),
regularlyhavingdifficulty fallingasleep (37.1%[3729of 10047]
to 63.0% [5312 of 8434]), and regularly experiencing night-
mares (26.2% [2667 of 10 166] to 49.5% [4138 of 8364]) at any
given timepoint. Theproportionof childrenwithactive atopic
dermatitis experiencing all 4 sleep-quality disturbances ac-
cording to child’s age is shown in Figure 2.
Incross-sectional analyses, childrenwithactiveatopicder-
matitis were more likely to report worse sleep-quality out-
comes at all ages (eTable 2 in the Supplement).We found evi-
dence for statistically significant interaction between atopic
dermatitis and comorbid asthmaor allergic rhinitis for the oc-
currence of impaired sleep-quality outcomes (overall test for
interaction P = .04; Table 3). Childrenwith only active atopic
dermatitishadnearly50%higheroddsof reportingmoresleep-
qualitydisturbances throughout childhood (adjustedodds ra-
tio [aOR], 1.48; 95% CI, 1.33-1.66), compared with those who
never reported atopic dermatitis. Children with both active
atopic dermatitis and either asthma or allergic rhinitis had
nearly80%increasedoddsof reportingmoresleep-qualitydis-
turbances throughout childhood (aOR, 1.79; 95% CI, 1.54-
2.09). In comparison, those with only asthma or allergic rhi-
nitis and no atopic dermatitis had about 40% greater odds of
reporting more sleep-quality disturbances throughout child-
hood (aOR, 1.42; 95% CI, 1.26-1.60).
More severe disease was associated with worse sleep-
quality outcomes, among children with and without comor-
bid asthma or allergic rhinitis (Table 3). For those with quite
badorverybadactivedisease, childrenwithonly active atopic
dermatitis had nearly 1.7 times the odds of reporting more
sleep-quality disturbances throughout childhood (aOR, 1.68;
95% CI, 1.42-1.98), and those with both active atopic derma-
titis andcomorbidasthmaorallergic rhinitishad2.15 times the
odds of reporting more sleep-quality disturbances through-
out childhood (aOR, 2.15; 95% CI, 1.75-2.64), compared with
thosewhonever reported atopic dermatitis. Childrenwith in-
active disease had similar odds of reporting more sleep-
quality disturbances (OR, 1.41; 95% CI, 1.28-1.55) as those
with active mild disease (OR, 1.40; 95% CI, 1.27-1.54), and
bothwere statistically significantly higher than the reference
group (Table 3). These results were largely consistent
across individual sleep-quality outcomes (eTables 3-6 in the
Supplement).
Multiple Imputation Results
Primary analyses yielded results that were largely consistent
with those estimated from the imputed data (eTables 3-8
in the Supplement). For sleep quality, estimates using the
imputed data were slightly attenuated toward the null;
however, results remained qualitatively similar and statisti-
cally significant. For sleep duration, the results were nearly
identical.
Discussion
Among the 13 988 children from the ALSPAC cohort followed
up frombirth throughadolescence,we foundsimilar sleepdu-
rationbetweenchildrenwithactiveatopicdermatitis andthose
without. In contrast, children with active atopic dermatitis
experienced worse sleep quality throughout childhood. This
associationwas largest among childrenwithmore severe dis-
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easeandamongchildrenwith comorbidasthmaor allergic rhi-
nitis,but it remainedstatisticallysignificantevenfor thosewith
inactive andmild disease.
These findings are consistent with those of small cross-
sectional studiesof clinicpopulations thatusedobjectivemea-
sures of sleep, including actigraphy andpolysomnography. In
Table 1. Cohort Characteristics
Variable Total, No. No. (%)
Without Atopic
Dermatitis
(n = 5555)
With Atopic
Dermatitis
(n = 4938)a P Valueb
Child, No. (%)
Male sex 13 978 7220 (51.7) 3008 (54.2) 2377 (48.1) <.001
White race/ethnicity 12 077 11 468 (95.0) 4755 (95.5) 4490 (95.7) .65
Asthma everc 12 612 3237 (25.7) 1058 (19.1) 1789 (36.2) <.001
Allergic rhinitis everc 10 156 1375 (13.5) 339 (7.8) 913 (20.3) <.001
Asthma or allergic rhinitis everc 12 620 3919 (31.1) 1272 (22.9) 2188 (44.3) <.001
Asthma and allergic rhinitis everc 12 620 693 (5.5) 125 (2.3) 514 (10.4) <.001
Maternal age at delivery, No. (%), y <.001
≤20 13 972 1004 (7.2) 375 (6.8) 212 (4.3)
21-34 13 972 11 585 (82.9) 4589 (82.6) 4196 (85.0)
≥35 13 972 1383 (9.9) 588 (10.6) 530 (10.7)
History of atopic condition, No. (%)d
Maternal 12 454 5659 (45.4) 2154 (42.0) 2402 (50.3) <.001
Paternal 8545 3418 (40.0) 1307 (36.8) 1543 (45.2) <.001
Household smoking exposure, No. (%)e 10 188 3683 (36.2) 1643 (37.7) 1476 (33.5) <.001
Maternal highest educational level, No. (%)f <.001
CSE/none 12 412 2504 (20.2) 1101 (21.5) 726 (15.2)
Vocational 12 412 1224 (9.9) 510 (9.9) 446 (9.3)
O level 12 412 4294 (34.6) 1833 (35.7) 1656 (34.7)
A level 12 412 2791 (22.5) 1130 (22.0) 1182 (24.8)
Degree 12 412 1599 (12.9) 559 (10.9) 762 (16.0)
Social class, No. (%)g <.001
Unskilled 12 254 227 (1.9) 86 (1.7) 54 (1.2)
Partly skilled 12 254 920 (7.5) 375 (7.5) 285 (6.2)
Skilled manual 12 254 1666 (13.6) 712 (14.2) 516 (11.2)
Skilled nonmanual 12 254 3780 (30.8) 1582 (31.6) 1390 (30.2)
Managerial and technical 12 254 4566 (37.3) 1862 (37.2) 1846 (40.1)
Professional 12 254 1095 (8.9) 391 (7.8) 508 (11.1)
Financial difficulties quartile, No. (%) .08
Lowest 12 083 4337 (35.9) 1798 (35.9) 1781 (38.4)
Mild 12 083 3006 (24.9) 1254 (25.1) 1142 (24.6)
Moderate 12 083 2324 (19.2) 970 (19.4) 862 (18.6)
Highest 12 083 2416 (20.0) 979 (19.6) 851 (18.4)
Crowding index, No. (%)h <.001
<0.5 12 799 5329 (41.6) 2058 (39.9) 2231 (46.9)
>0.5-0.75 12 799 4013 (31.3) 1623 (31.5) 1509 (31.7)
>0.75-1 12 799 2579 (20.2) 1106 (21.5) 810 (17.0)
>1 12 799 878 (6.9) 368 (7.1) 207 (4.4)
Abbreviation: CSE, Certificate of Secondary Education.
a Children whomet the definition of atopic dermatitis by age 16 years (ie, had at
least 2 reports of flexural dermatitis). There were 3505 individuals with only
1 report of flexural dermatitis.
b χ2 Test comparing children who never reported atopic dermatitis with children
who ever reported atopic dermatitis through age 16 years.
c At least 2 reports of symptoms throughout childhood.
d Including atopic dermatitis, asthma, or allergic rhinitis.
e At 1.75 years of age.
f UK educational levels: CSE, certificate after passing national school
examinations at 16 years of age; vocational; O level, qualification after passing
national school examinations at 16 years of age; higher than CSE; A level,
qualification after passing national school examinations at 18 years of age;
degree, university degree, or higher.
g Highest of either parent, based on occupation.
h The number of persons living in the household divided by the number of
rooms in that household.
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those studies, despite increases in sleep fragmentationand re-
ductions in sleep efficiency, overall sleep duration was simi-
lar between children with and without atopic dermatitis.6-10
In contrast, time spent awake after sleep onset is consistently
greater among children with atopic dermatitis, ranging from
approximately 45 to 100minutes.6-9 In addition to increased
nighttime awakenings and difficulty falling asleep, we found
that childrenwith active atopic dermatitisweremore likely to
report nightmares and early morning awakenings, which has
not been previously studied.10
A strength of this longitudinal study was that it enabled
us to examine the association between sleep and atopic der-
matitis activity and severity at multiple time points through-
out childhood, allowing a look at sleep outcomes of indi-
viduals whose disease was no longer active at any given time
point. Children with inactive disease still reported increased
odds of impaired sleep quality, at a level similar to those
with active but mild disease. Our findings are consistent
with previous data from a polysomnographic study: Despite
being in a period of clinical remission, children with a his-
tory of previously active atopic dermatitis experienced a
substantially higher number of arousals and awakenings
compared with controls.28 Moreover, scratching episodes
only accounted for 15% of the arousals and awakenings, sug-
gesting that scratching alone does not explain the sleep frag-
mentation experienced by these patients.28 Fishbein and
colleagues5 have proposed that this phenomenon may be
associated with a heightened sensitivity to sensory stimula-
tion at night secondary to skin damage, whichmay represent
an underlying mechanism of hyperarousability despite good
disease control.6,29 Other factors that may be implicated in
atopic dermatitis–associated sleep disturbances include
Table 2. Estimated Differences in Sleep Duration According
to Atopic Dermatitis Disease Activity and Severitya
Disease Activity
and Severity
Estimated Difference
in Sleep Duration (95% CI), min
Unadjusted Adjusted
Nighttime sleep durationb,c
Never reported atopic
dermatitis
1 [Reference] 1 [Reference]
Overall active atopic dermatitis −8 (−10 to −6) 0 (−2 to 2)
No problem −9 (−13 to −6) 1 (−2 to 4)
Mild −11 (−13 to −9) 1 (−1 to 3)
Quite bad −7 (−10 to −5) 0 (−2 to 2)
Very bad −5 (−10 to 0) −1 (−6 to 3)
Inactive atopic dermatitis −33 (−35 to −32) 2 (1 to 4)
Total sleep durationd,e
Never reported atopic
dermatitis
1 [Reference] 1 [Reference]
Overall active atopic dermatitis −10 (−13 to −8) −2 (−4 to 0)
No problem −15 (−19 to −10) −2 (−5 to 1)
Mild −17 (−19 to −14) −2 (−4 to −1)
Quite bad −8 (−11 to −5) −1 (−4 to 1)
Very bad −3 (−8 to 2) −3 (−7 to 1)
Inactive atopic dermatitis −43 (−45 to −42) −1 (−3 to 0)
a Results from unadjusted and adjustedmultivariable mixed-effects linear
regressionmodels examining the association between atopic dermatitis and
nighttime and total sleep duration at 8 time points (30, 42, 57, 69, 81, 115, 140,
and 186months) between ages 2 and 16 years. Themultivariable model
adjusted for potential confounders, including child’s sex, age, race/ethnicity,
and comorbid asthma or allergic rhinitis; household smoking exposure;
maternal educational level, social class, and age at delivery; crowding index;
and financial difficulties score.
bUnadjustedmodel with 11 549 individuals; mean (range) of 5.3 (1-8)
observations per individual.
c Adjustedmodel with 9109 individuals; mean (range) of 5.0 (1-7) observations
per individual.
dUnadjustedmodel with 11 531 individuals; mean (range) of 5.3 (1-8)
observations per individual.
e Adjustedmodel with 9101 individuals; mean (range) of 5.0 (1-7) observations
per individual.
Figure 2. Proportion of ChildrenWith Active Atopic Dermatitis
Experiencing Sleep-Quality Disturbances by Child Age
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Proportion of children with active atopic dermatitis reporting each of the 4
sleep-quality disturbances based on cross-sectional data at different child ages.
Table 3. Adjusted Participant-Specific Odds of ReportingMore
Sleep-Quality Disturbances According to Atopic Dermatitis Disease
Activity and Severitya,b
Disease Activity
and Severity
Odds Ratio (95% CI)
Without Asthma or
Allergic Rhinitis
With Asthma or
Allergic Rhinitis
Never reported atopic
dermatitis
1 [Reference] 1 [Reference]
Overall active atopic
dermatitis
1.48 (1.33-1.66) 1.79 (1.54-2.09)
No problem 1.24 (1.04-1.48) 1.52 (1.07-2.16)
Mild 1.40 (1.27-1.54) 1.47 (1.26-1.71)
Quite bad 1.51 (1.32-1.73) 2.03 (1.66-2.48)
Very bad 1.85 (1.41-2.45) 2.28 (1.65-3.15)
Inactive atopic dermatitis 1.41 (1.28-1.55) 1.52 (1.31-1.77)
a Results from an adjustedmultivariable mixed-effects ordinal logistic
regressionmodel examining the association between atopic dermatitis and a
composite measure of sleep quality (including nighttime awakenings, early
morning awakenings, difficulty going to sleep, and nightmares) at 6 time
points (30, 42, 57, 69, 81, and 115 months) between ages 2 and 10 years.
Themodel adjusted for potential confounders, including child’s sex, age,
race/ethnicity, and comorbid asthma or allergic rhinitis; household smoking
exposure; maternal educational level, social class, and age at delivery;
crowding index; and financial difficulties score as well as an interaction term
between atopic dermatitis and comorbid asthma or allergic rhinitis. Model
with 9112 individuals; mean (range) of 4.5 (1-6) observations per individual.
bOverall test for interaction: P = .04.
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cytokine and melatonin dysregulation and disrupted circa-
dian rhythms of the skin.30
From a clinical perspective, our findings suggest that pe-
diatricians should consider screening all childrenwith atopic
dermatitis, even if their disease ismildorno longer active. Cli-
nicians may offer anticipatory guidance, education, behav-
ioral interventions, and referrals if appropriate.31-33 Early de-
tection and management of sleep problems in children with
atopic dermatitis is critical to prevent quality-of-life impair-
ments, daytime fatigue, as well as behavioral and mood dis-
orders reported inchildrenwithatopicdermatitis.2,9,10,34,35Ad-
ditional research is needed to understand whether more
aggressive treatment of atopic dermatitis symptomswill lead
to improvements in children’s sleep quality.
Sleep disturbances have been studied separately in chil-
dren with asthma and allergic rhinitis, but few studies have
examined differences in sleep quality in children with more
than 1 atopic condition.10,36,37 One of the strengths of the
current study is the inclusion of several time-varying covari-
ates, notably, asthma and allergic rhinitis, which were mea-
sured at all of the same time points as the primary exposure.
We found that children with both atopic dermatitis and
comorbid asthma or allergic rhinitis reported substantially
more sleep-quality impairments, which has important clini-
cal and therapeutic implications. This result suggests that
children with several atopic diseases may represent a group
at higher risk of experiencing disrupted sleep and its conse-
quences, including impaired quality of life, daytime fatigue,
poor school performance, and behavioral problems. Clini-
cians caring for children with several atopic conditions
should inquire about nocturnal symptoms and sleep distur-
bances during routine clinic visits and should consider treat-
ing these conditions more aggressively.
Limitations
This study has several limitations thatwarrant discussion. As
in all large-scale longitudinal studies, the study was missing
data and attrition occurred over time. For this reason, we re-
peated the analyses after conductingmultiple imputationand
found that the resultswere similar,whichhelpedaddress con-
cerns of potential selection bias.
Another important limitation was the possibility for mis-
classificationbias, becausebothexposure andoutcomeswere
parent- or self-reported. Previous studies have found that pa-
rental report closely approximates physician assessment of
atopic dermatitis,38 and the estimates of the annual period
prevalence of atopic dermatitis were consistent with UK esti-
mates from the population-based ISAAC study, which in-
cluded physical assessment in childhood.39 Our findings for
both sleep duration and quality were highly consistent with
smaller studies that used objective measures of sleep. Com-
parisons betweenparental assessment of children’s sleep and
objectivemeasures, includingpolysomnography and actigra-
phy, have found that parents tend to overestimate sleep du-
ration andunderestimate nighttime awakenings,40-42 both of
which would tend to bias our results toward the null. Al-
though our compositemeasure for sleep quality has not been
validated, it included items that are similar to those in theChil-
dren’s Sleep Habits Questionnaire, a validated and reliable
screening instrument to identify sleep problems in school-
aged children.43 In addition, although our cohort is fairly rep-
resentative of theUKpopulation,14 the extent towhichour re-
sults are generalizable to other settings is unclear.
Notwithstanding these limitations, this study has several
implications for future research and clinical care. Currently,
only a few atopic dermatitis clinical outcome measures ad-
dress sleepandmaynotadequatelycapture theextentof sleep-
quality disturbances.44,45 Our findings support the develop-
mentof standardizedandvalidatedclinical outcomemeasures
of sleep disturbance that explicitly address several aspects of
sleep quality.45,46 This refinement would enable future trials
to assess the effectiveness of atopic dermatitis interventions
in reducing poor sleep.
Conclusions
Atopic dermatitis appeared to negatively affect sleep quality
throughout childhood, evenamongpatientswithmild and in-
active disease. Increasing disease severity and comorbid
asthmaorallergic rhinitis appeared tobeassociatedwithworse
sleep-quality outcomes. Clinical outcomemeasures for atopic
dermatitis should explicitly address sleep quality, and addi-
tionalwork should investigate interventions to improve sleep
quality and examine the association between atopic dermati-
tis treatment and children’s sleep.
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